Get the app
USHealthcare

PACS Group, Inc. (PACS)

US · Healthcare · Medical Care Facilities

$42.06-1.54%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$1.43B
Revenue YoY
+9.1%
Net profit
$76.4M
Profit YoY
+49.9%
EPS
$0.63
EPS estimate
$0.55
Net margin
5.3%

EPS came in at 0.63 against a street estimate of 0.55 — a beat of 14.5%.

Key statistics

Market cap
$7.08B
P/E
26.2
Forward P/E
16.9
P/B
6.38
Book value
$7.01
EPS (TTM)
$1.71
52-week high
$49.49
52-week low
$10.31
50-day MA
$44.78
200-day MA
$38.22
Beta
-0.13

Analyst view

Analysts rate PACS Group, Inc. a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $59.00.

From the latest earnings call · 2026-08-05

CONFIDENT PACS delivered Q2 revenue +9.1% YoY to $1.43B; net income +50%; adjusted EBITDA +25% with margin expansion to 11.7%. Same-store occupancy up 150bps. Raised FY26 guidance; closed 20 Eduro Texas facilities; 14 more expected Q3-Q4. Q2 2026 Eduro transaction adds 3,633 SNF beds across Texas, Montana, South Dakota, North Dakota, New Mexico, Utah. First 20 facilities closed August 1, 2026; remainder expected Q3-Q4. Analysts pressed on back-half momentum, ramping cohort drivers, and payer dynamics. Management emphasized quality as competitive moat, confirmed modest Eduro integration, flagged pending Ohio/California supplemental payments as upside not in guidance. 2026-08-05…

Full summary in the app.

Shareholding

Insiders
69.10%
Institutions
31.59%

Largest institutional holders

FundStake
Cohen & Steers Inc5.27%
FMR Inc3.31%
BlackRock Inc2.38%
Crewe Advisors LLC2.09%
American Century Companies Inc1.96%
Alyeska Investment Group, L.P.1.90%
Vanguard Portfolio Management, LLC1.18%
Vanguard Capital Management, LLC1.14%

Recent filings & reports

DocumentDate
Quarterly report · Q2 2026
PACS GROUP, INC. – Q2 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Total Revenue (6 months): $2,848.5 million (up 10.1% vs. $2,586.4 million in 2025) •
2026-08-04
Results announced · Q3 2026
PACS GROUP, INC. — Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue: $1.43 billion in Q2 2026, up 9.1% year-over-year • Net income: $76.3 million
2026-08-04
Shareholder vote results · Q2 2026
PACS GROUP, INC. – DOCUMENT SUMMARY HEADLINE NUMBERS • Annual Meeting Date: June 10, 2026 • Shareholder Participation: 152,966,362 shares represente
2026-06-15
Quarterly report · Q1 2026
PACS GROUP, INC. – Q1 2026 FORM 10-Q SUMMARY HEADLINE NUMBERS • Total Revenue: $1,420,494 thousand (Q1 2026) vs. $1,277,150 thousand (Q1 2025) – up
2026-05-11
Results announced · Q2 2026
PACS GROUP, INC. - Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue: $1.42 billion, up 11.2% year-over-year • Net income: $80.7 million, up 184.2
2026-05-11
Proxy statement · Q2 2026
PACS GROUP, INC. — 2026 PROXY STATEMENT SUMMARY --- WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1 (Election of Directors): Elect Evelyn Dilsaver and
2026-04-28
Board / officer change · Q2 2026
PACS GROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • New CFO appointment effective April 27, 2026: Carey Hendrickson (age 63) • Base salary: $475,
2026-04-27
Annual report FY2025
PACS GROUP, INC. – FORM 10-K SUMMARY HEADLINE NUMBERS • Company operates 321 post-acute care facilities across 17 states serving over 31,700 patient
2026-02-27

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for PACS Group, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.